177 related articles for article (PubMed ID: 29368093)
1. Parkinson's Disease, the Dopaminergic Neuron and Gammahydroxybutyrate.
Mamelak M
Neurol Ther; 2018 Jun; 7(1):5-11. PubMed ID: 29368093
[TBL] [Abstract][Full Text] [Related]
2. The Treatment of Parkinson's Disease with Sodium Oxybate.
Mamelak M
Curr Mol Pharmacol; 2023; 16(5):564-579. PubMed ID: 36330625
[TBL] [Abstract][Full Text] [Related]
3. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Hill WD; Arai M; Cohen JA; Trojanowski JQ
J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
5. Calcium, ageing, and neuronal vulnerability in Parkinson's disease.
Surmeier DJ
Lancet Neurol; 2007 Oct; 6(10):933-8. PubMed ID: 17884683
[TBL] [Abstract][Full Text] [Related]
6. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
7. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
8. The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson's Disease.
Norwitz NG; Hu MT; Clarke K
Front Nutr; 2019; 6():63. PubMed ID: 31139630
[TBL] [Abstract][Full Text] [Related]
9. Calcium, Dopamine and Neuronal Calcium Sensor 1: Their Contribution to Parkinson's Disease.
Catoni C; Calì T; Brini M
Front Mol Neurosci; 2019; 12():55. PubMed ID: 30967759
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 7 inhibition induces dopaminergic neurogenesis in hemiparkinsonian rats.
Morales-Garcia JA; Alonso-Gil S; Gil C; Martinez A; Santos A; Perez-Castillo A
Stem Cells Transl Med; 2015 Jun; 4(6):564-75. PubMed ID: 25925836
[TBL] [Abstract][Full Text] [Related]
11. Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways.
Zhang J; Niu N; Wang M; McNutt MA; Zhang D; Zhang B; Lu S; Liu Y; Liu Z
Int J Biochem Cell Biol; 2013 Aug; 45(8):1911-20. PubMed ID: 23791745
[TBL] [Abstract][Full Text] [Related]
12. TRPC Channels and Parkinson's Disease.
Sukumaran P; Sun Y; Schaar A; Selvaraj S; Singh BB
Adv Exp Med Biol; 2017; 976():85-94. PubMed ID: 28508315
[TBL] [Abstract][Full Text] [Related]
13. Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.
Surmeier DJ; Halliday GM; Simuni T
Exp Neurol; 2017 Dec; 298(Pt B):202-209. PubMed ID: 28780195
[TBL] [Abstract][Full Text] [Related]
14. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease.
Chan CS; Guzman JN; Ilijic E; Mercer JN; Rick C; Tkatch T; Meredith GE; Surmeier DJ
Nature; 2007 Jun; 447(7148):1081-6. PubMed ID: 17558391
[TBL] [Abstract][Full Text] [Related]
15. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
[TBL] [Abstract][Full Text] [Related]
16. The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease.
Pissadaki EK; Bolam JP
Front Comput Neurosci; 2013; 7():13. PubMed ID: 23515615
[TBL] [Abstract][Full Text] [Related]
17. Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS Clearance.
Lu M; Su C; Qiao C; Bian Y; Ding J; Hu G
Int J Neuropsychopharmacol; 2016 Sep; 19(9):. PubMed ID: 27207919
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
Porritt MJ; Batchelor PE; Howells DW
Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
[TBL] [Abstract][Full Text] [Related]
19. Energy and the Alzheimer brain.
Mamelak M
Neurosci Biobehav Rev; 2017 Apr; 75():297-313. PubMed ID: 28193453
[TBL] [Abstract][Full Text] [Related]
20. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
Duda J; Pötschke C; Liss B
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
